FDA FY 2019 Budget Justification Light On Cosmetics Progam Details
This article was originally published in The Rose Sheet
Executive Summary
There’s no new wealth of information on FDA’s cosmetics activities in its justification for proposed fiscal 2019 spending, potentially signaling that cosmetics will remain a low-priority area for the agency.
You may also be interested in...
Rep. Pallone Seeks FDA Update On Imported Cosmetics; Input On Legislation Requested
The Democratic congressman from New Jersey requests updated data on imported cosmetics and FDA’s related inspection work in a June 26 letter to agency leadership, which follows a similar inquiry from Pallone in 2016. Further, he asks for any additional information that might inform the development of cosmetics reform legislation.
FDA Targets Spring 2019 For Cosmetics Manufacturing Survey; PCPC Input Taken
From the Personal Care Products Council’s standpoint, FDA’s planned survey of current manufacturing practices in the cosmetics sector isn’t necessary, but the group provided input to contractor RTI to help develop the instrument for optimal utility. Pending OMB approval, FDA aims to launch the survey in spring 2019.
Feminine Cleanser Marketing Never Without Challenges; Now The Category Has FDA’s Attention
FDA is investigating use of certain ingredients in feminine cleansing and hygiene products, according to its fiscal 2019 budget justification. The agency’s work could draw unfavorable attention to a category that already comes under fire regularly for alleged body shaming and disproportionate ill effects on women of color, among other accusations.